Our data were in agreement with Zhao et al., which demonstrated that treatment of HSCs with AML exosomes containing miR-4532 reduced CFU formation and increased the expression of DKK1, a hematopoietic inhibiting factor (3). This evidence concerns the gene DKK1 and acute myeloid leukemia.